🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 22 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/11/2017 74,05 74,05 71,73 71,81 -3,21% 3,13% 673.800
21/11/2017 72,00 74,30 72,00 74,19 +3,37% 3,19% 611.800
20/11/2017 72,01 72,39 70,82 71,77 -0,71% 2,18% 529.700
17/11/2017 70,95 72,48 70,56 72,28 -0,03% 2,71% 866.100
16/11/2017 72,64 73,40 72,11 72,30 +0,36% 1,78% 637.200
15/11/2017 74,11 74,11 71,86 72,04 -2,87% 3,04% 915.800
14/11/2017 74,19 74,86 71,62 74,17 -0,63% 4,37% 832.500
13/11/2017 75,12 75,64 74,42 74,64 -1,09% 1,62% 604.000
10/11/2017 75,06 75,83 74,01 75,46 +0,05% 2,42% 768.500
09/11/2017 74,04 75,55 73,28 75,42 +1,85% 3,07% 886.700
08/11/2017 74,99 75,98 73,54 74,05 -0,64% 3,25% 1.071.100
07/11/2017 73,33 75,40 73,07 74,53 +0,03% 3,18% 1.056.400
06/11/2017 73,60 75,22 72,33 74,51 +1,40% 3,93% 1.465.100
03/11/2017 73,00 74,42 71,48 73,48 +0,96% 4,03% 2.429.400
02/11/2017 71,05 74,96 68,09 72,78 +19,45% 9,67% 5.674.100
01/11/2017 62,68 62,99 60,38 60,93 -1,90% 4,16% 1.442.900
31/10/2017 62,11 62,81 61,14 62,11 +0,06% 2,69% 700.100
30/10/2017 62,08 63,40 61,52 62,07 -0,11% 3,03% 885.700
27/10/2017 59,69 62,15 59,31 62,14 +4,70% 4,76% 1.007.200
26/10/2017 58,84 59,67 57,74 59,35 +0,58% 3,28% 822.200
25/10/2017 59,18 60,28 58,30 59,01 +0,08% 3,35% 761.000
24/10/2017 58,79 59,42 57,91 58,96 +0,73% 2,57% 767.200
23/10/2017 59,12 59,29 58,16 58,53 -0,85% 1,91% 808.800
20/10/2017 58,59 60,56 57,71 59,03 +0,12% 4,86% 1.279.500
19/10/2017 59,04 59,46 58,35 58,96 -0,77% 1,88% 620.200
18/10/2017 61,53 61,66 59,35 59,42 -2,38% 3,75% 652.800
17/10/2017 61,24 61,43 60,58 60,87 -0,44% 1,39% 610.900
16/10/2017 62,01 62,75 61,09 61,14 -1,63% 2,68% 543.500
13/10/2017 62,12 63,04 61,99 62,15 -0,29% 1,69% 437.900
12/10/2017 61,88 62,50 61,01 62,33 +0,76% 2,41% 663.500